Zygomaticomaxillary complex fracture. Fracture of malar, maxillary and zygoma bones, unspecified
Conditions
Interventions
Intervention 1: Intervention group: At time intervals of 0, 6, 12, and 24 hours before transfer to the operating room, patients will receive a 40 mL glass of fruit juice containing 10 mg of monteluka
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The participating patients who have zygomaticomaxillary complex fracture Patients aged between 18 and 60 years Patients of both sexes, male and female Patients with a BMI of less than 30 kg/m² (non-obese)
Exclusion criteria
Exclusion criteria: Preoperative use or dependence on narcotic drugs Having peptic ulcer disease, hepatic or renal dysfunction, or psychiatric disorders Allergy to amide local anesthetics and narcotics, and a history of seizures Cases where the participant requires intensive care unit admission after surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity score measured using the Visual Analogue Scale from 0 to 10, in patients undergoing surgery for zygomaticomaxillary complex fractures, comparing Montelukast and control groups. Timepoint: Pain intensity will be assessed immediately after recovery and every two hours for a total duration of 12 hours. Method of measurement: The outcome was measured using the Visual Analogue Scale for pain intensity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarokh Farhadi Shabestari
Tabriz University of Medical Sciences
Outcome results
None listed